Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Why Teladoc (TDOC) Stock Has More Than Doubled In A Year

By Zacks Investment ResearchStock MarketsMar 06, 2018 09:23PM ET
www.investing.com/analysis/why-teladoc-tdoc-stock-has-more-than-doubled-in-a-year-200296355
Why Teladoc (TDOC) Stock Has More Than Doubled In A Year
By Zacks Investment Research   |  Mar 06, 2018 09:23PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
GS
+1.13%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MS
+0.92%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TVTY
+0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AMN
+1.17%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TDOC
-11.69%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MEDP
-1.79%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Despite posting loss since its IPO in June 2015, the stock price of Teladoc, Inc. (NYSE:TDOC) , a telehealth service provider, has only moved up.

Stock price, which is often largely influenced by earnings, is not replicated in case of Teladoc. In fact, the stock has surged 119% in a year’s time, significantly outshining the industry’s growth of 6.9%.

What’s Supporting the Rally?

Investors note that the company is in the inception phase and losses are a result of heavy expenditures incurred on marketing and substantial investments made to acquire new clients, build its proprietary network of healthcare providers and develop its technology platform.

All the more encouraging is that these investments are bearing fruit, which is reflected by a strong increase in membership, visits and client base. These drives have led to an upsurge in revenues at the company that has witnessed a CAGR of 74% from 2014-2017.

The company’s inorganic strategies have provided enough fuel for overall growth. A number of acquisitions, Best Doctors, HealthiestYou, StatDoc and BetterHelp completed in past three years have led to an increase in membership and visits. Both these metrics have seen a CAGR of 42% and 70%, respectively from 2014-2017.

Investors also are confident about a decline in expenditure as the company has gradually started to realize leverage from the scale of its operations. In the fourth quarter of 2017, the company reported positive EBIDTA (first ever since its IPO) which shows that it is on track to achieve profitability.

Uniquely Positioned in a Burgeoning Industry

Teladoc is fast gaining ground in the rapidly growing telehealth services industry in the U.S., which has ample scope owing to increasing health care costs following inefficient care, duplication of services, significant waste and extreme variation in access, cost and quality of care.

Teladoc fills in this inefficiency by providing superior quality of care through a platform that caters to consumer demand and physician availability in real-time and in various modalities such as video, web, mobile and telephone. Moreover, the emergence of technology such as big data and analytics, cloud-based solutions, online video and mobile applications present the company with huge scope for growth.

Will the Stock Rally Further?

The company’s strong guidance for 2018 gives further positive insight into its performance going forward, which should support its stock price rally.

Teladoc expects net loss per share, based on 62.8 million weighted average shares outstanding, between $1.36 and $1.41 (lower than $1.93 in 2017); revenues in the range of $350 million to $360 million (up 55% at mid point); adjusted EBITDA between $7 million and $10 million (compared with negative EBIDTA of $70.4 million in 2017) and total U.S. paid membership within 22 million to 24 million.

Total visits are projected between 1.9 million and 2 million (up 33% year over year).

Zacks Rank and Stocks to Consider

Teladoc carries a Zacks Rank #3 (Hold). Investors interested in the Medical sector can consider some better-ranked stocks like Tivity Health, Inc. (NASDAQ:TVTY) , AMN Healthcare Services, Inc. (NYSE:AMN) and Medpace Holdings, Inc. (NASDAQ:MEDP) . While Tivity Health sports a Zacks Rank #1 (Strong Buy) the other two carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Tivity Health delivered positive surprises in each of the last four quarters, with an average beat of 21.8%.

AMN Healthcare Services surpassed estimates in three of the four reported quarters with an average positive surprise of 4.99%.

Medpace Holdings beat estimates in two of the four reported quarters with an average positive surprise of 7.42%.

Breaking News: Cryptocurrencies Now Bigger than Visa

The total market cap of all cryptos recently surpassed $700 billion – more than a 3,800% increase in the previous 12 months. They’re now bigger than Morgan Stanley (NYSE:MS), Goldman Sachs (NYSE:GS) and even Visa! The new asset class may expand even more rapidly in 2018 as new investors continue pouring in and Wall Street becomes increasingly involved.

Zacks’ has just named 4 companies that enable investors to take advantage of the explosive growth of cryptocurrencies via the stock market.

Click here to access these stocks >>



AMN Healthcare Services Inc (AMN): Free Stock Analysis Report

Teladoc, Inc. (TDOC): Free Stock Analysis Report

Healthways, Inc. (TVTY): Free Stock Analysis Report

Medpace Holdings, Inc. (MEDP): Free Stock Analysis Report

Original post

Why Teladoc (TDOC) Stock Has More Than Doubled In A Year
 

Related Articles

Why Teladoc (TDOC) Stock Has More Than Doubled In A Year

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email